IGF2 and colorectal carcinoma: For example, TFRC, S100A8, MYD88, and IGF2 were suggested to be upregulated in EVs from patients with CRC, particularly in patients with stage IV tumors, with p‐values less than 0.01 in three MWW tests, and comparatively higher importance scores were obtained in either or both of the RF analyses.